Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
7.42
+0.05 (0.68%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$310,222
Profits / Employee
-$47,148
Market Cap
683.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
MYGN News
- 2 days ago - Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting - GlobeNewsWire
- 6 days ago - Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing - GlobeNewsWire
- 19 days ago - Myriad Genetics Announces Inducement Awards - GlobeNewsWire
- 20 days ago - Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer - GlobeNewsWire
- 2 months ago - Myriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage, Appoints New CEO - Benzinga
- 2 months ago - Myriad Genetics, Inc. (MYGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth - GlobeNewsWire
- 2 months ago - Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio - GlobeNewsWire